Clinical Trial Detail

NCT ID NCT01707004
Title Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide

Decitabine

Filgrastim

Fludarabine

Busulfan

Age Groups: adult

No variant requirements are available.